Dr. Agarwal's Health Care Limited (BOM:544350)
479.10
-2.40 (-0.50%)
At close: Jul 31, 2026
Dr. Agarwal's Health Care Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 151,518 | 128,798 | 140,835 | - | - | - | |
Market Cap Growth | 5.29% | -8.55% | - | - | - | - |
Enterprise Value | 160,285 | 135,537 | 146,808 | - | - | - |
Last Close Price | 479.10 | 406.15 | 446.90 | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 113.76 | 96.70 | 168.75 | - | - | - |
PS Ratio | 7.28 | 6.19 | 8.23 | - | - | - |
PB Ratio | 7.15 | 6.08 | 7.31 | - | - | - |
P/TBV Ratio | 17.36 | 14.76 | 20.88 | - | - | - |
P/FCF Ratio | 213.29 | 181.30 | 272.51 | - | - | - |
P/OCF Ratio | 29.19 | 24.82 | 39.09 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 7.71 | 6.52 | 8.58 | - | - | - |
EV/EBITDA Ratio | 28.20 | 23.80 | 38.42 | - | - | - |
EV/EBIT Ratio | 54.66 | 46.21 | 63.84 | - | - | - |
EV/FCF Ratio | 225.63 | 190.79 | 284.07 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.50 | 0.50 | 0.50 | 0.70 | 1.30 | 2.71 |
Debt / EBITDA Ratio | 1.87 | 1.87 | 2.09 | 2.67 | 3.20 | 3.69 |
Debt / FCF Ratio | 15.01 | 15.01 | 18.59 | 8.40 | 11.20 | 6.73 |
Net Debt / Equity Ratio | 0.37 | 0.37 | 0.23 | 0.28 | 1.06 | 2.28 |
Net Debt / EBITDA Ratio | 1.38 | 1.38 | 1.17 | 1.29 | 3.20 | 3.82 |
Net Debt / FCF Ratio | 11.05 | 11.05 | 8.68 | 3.34 | 9.10 | 5.67 |
Asset Turnover | 0.55 | 0.55 | 0.53 | 0.58 | 0.71 | 0.77 |
Inventory Turnover | 13.26 | 13.26 | 14.93 | 17.43 | 16.99 | 13.24 |
Quick Ratio | 0.96 | 0.96 | 1.44 | 1.71 | 0.80 | 0.80 |
Current Ratio | 1.24 | 1.24 | 1.66 | 1.90 | 1.03 | 1.10 |
Return on Equity (ROE) | 8.31% | 8.31% | 6.67% | 9.32% | 23.12% | 19.96% |
Return on Assets (ROA) | 4.82% | 4.82% | 4.47% | 5.24% | 6.31% | 5.84% |
Return on Invested Capital (ROIC) | 7.20% | 7.51% | 7.67% | 8.32% | 13.57% | 9.34% |
Return on Capital Employed (ROCE) | 8.40% | 8.40% | 7.20% | 8.20% | 9.50% | 10.30% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 0.88% | 1.03% | 0.59% | - | - | - |
FCF Yield | 0.47% | 0.55% | 0.37% | - | - | - |
Payout Ratio | 0.82% | 0.82% | 0.95% | 0.93% | 0.46% | 0.02% |
Buyback Yield / Dilution | -6.27% | -6.27% | -13.09% | -12.46% | -14.56% | - |